The role of apoptosis in neurodegenerative diseases

Metabolic Brain Disease

Volumn 13, Issue 2, 1998, Pages 79-96

  Desjardins, Paul ^a   Ledoux, Stéphane ^a  

^a Neuroscience Research Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLTETRAHYDROPYRIDINE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CALCIUM ION; COPPER ZINC SUPEROXIDE DISMUTASE; DNA; GLUTAMINE; HUNTINGTIN; INTERLEUKIN 1BETA CONVERTING ENZYME; NEUROTOXIN; OXIDOPAMINE; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CELL DEATH; CELL LOSS; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; MACHADO JOSEPH DISEASE; NONHUMAN; PARKINSON DISEASE; REVIEW; SPINAL MUSCULAR ATROPHY; SPINOCEREBELLAR DEGENERATION;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; HUMANS; HUNTINGTON DISEASE; MOTOR NEURON DISEASE; NECROSIS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 0031826405     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020605112755     Document Type: Review

References (136)

1. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87:171.
2. Anderson, A.J., Pike, C.J., and Cotman, C.W. (1995). Differential induction of IEGs in response to Aβ peptides in cultured neurons: association between c-Jun immunoreactivity and Aβ-mediated apoptosis. J. Neurochem. 65:1487-1498.
3. Anderson, A.J., Su, J.H., and Cotman, C.W. (1996). DNA damage and apoptosis in Alzheimer's disease: colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1710-1719.
4. Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M.T., Michel, P.P., Marquez, J., et al. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. & Histopathol. 12:25-31.
5. Appel, S.H. (1981). A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann. Neurol 10:499-505.
6. Behl, C., Davis, J., Cole, G., and Schubert, D. (1992). Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophy. Res. Commun. 186:944-950.
7. Behl, C., Davis, J.B., Klier, F.G., and Schubert, D. (1994a). Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:253-264.
8. Behl, C., Davis, J., Lesley, R., and Schubert, D. (1994b). Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
9. Blum, D., Wu, Y., Nissou, M.F., Arnaud, S., Benabid, A.L., and Verna, J.M. (1997). p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Res. 751:139-142.
10. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, A.S. (1995). Apoptosis and necrosis: two distincts events induced, respectively by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92:7162-7166.
11. Burek, M.J., and Oppenheim, R.W. (1996). Programmed cell death in the developing nervous system Brain Pathol. 6:427-446.
12. Cerretti, D.P., Kozlosky, C.J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T.A. et al. (1992). Molecular cloning of the interleukin-1β converting enzyme. Science 256:97-100.
13. Charriaut-Marlangue, C., and Ben-Ari, Y. (1995). A cautionary note on the use of the TUNEL stain to determine apoptosis. NeuroReport 7:61-64.
14. Choi, D.W. (1992). Excitotoxic cell death. J. Neurobiol. 23:1261-1276.
15. Cleary, M.L., Smith, S.D., and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28.
16. Cleeter, M.W.J., Cooper, J.M., and Schapira, A.H.V. (1992). Irreversible inhibition of mitochondrial complex I by 1-methyl-4-pyridinium: evidence for free radical involvement. J. Neurochem. 58:186-189.
17. Clermont, O., Burlet, P., Burglen, L., Lefebvre, S., Pascal, F., McPherson, J. et al. (1994). Use of genetic and physical mapping to locate the spinal muscular atrophy locus between two new highly polymorphic DNA markers. Am. J. Hum. Genet. 54:687-694.
18. Coyle, J.T., and Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
19. + binds to neuromelanin. Science 231:987-989.
20. Deng, H.-X., Hentati, A., Tainer, J.A., Iqbal, Z., Cayabyab, A., Hung ,W.-Y. et al. (1993). Amyotrophic lateral sclerosis and structural defects in Cu, Zn Superoxide dismutase. Science 261:1047-1051.
21. Deng, G., Pike, C.J., and Cotman, C.W. (1996). Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397:50-54.
22. Di Monte, D., Wu, E.Y., and Langsten, W. (1992). Role of astrocytes in MPTP metabolism and toxicity. Ann. NY Acad. Sci. 648:219-228.
23. Dragunow, M., Faull, R.L.M., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B., and Mee, E. (1995). In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport 6:1053-1057.
24. Du, Y., Bales, K.R., Dodel, R.C., Hamilton-Byrd, E., Horn, H.W., Czilli, D.L. et al. (1997). Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA 94:11,657-11,662.
25. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti ,F., Barnes, G.T., McNeil, S.M., et al. (1995). Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407-410.
26. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. (1998). A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391:43-50.
27. Estévez, A.G., Radi, R., Barbeito, L., Shin, J.T., Thompson, J.A., and Beckman, J.S. (1995). Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65:1543-1550.
28. Estévez, A.G., Spear,N., Manuel, S.M., Radi, R., Henderson, C.E., Barbeito, L., and Beckman, J.S. (1998). Nitric oxide and Superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J. Neurosci. 18:923-931.
29. Estus, S., Zaks, W.J., Freeman, R.S., Gruda, M., Bravo, R., and Johnson, E.M. (1994). Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell. Biol. 126:1717-1727.
30. Fesus, L., Thomazy, V., and Falus, A. (1987). Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:104-108.
31. Fesus, L., Thomazy, V., Autuori, F., Ceru, M.P., Tarcsa, E., and Piacentini, M. (1989). Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245:150-154.
32. Forloni, G., Chiesa, R., Smiroldo, S, Verga, L., Salmona, M., Tagliavini, F., and Angeretti N. (1993). Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. NeuroReport 4:523-526.
33. Forno, L.S., DeLanney, L.E., Irwin, I., Di Monte, D., and Langston, J.W. (1992). Astrocytes and Parkinson's disease. Prog. Brain Res. 94:429-436.
34. Fridovich, I (1986). Superoxide dismutases. Adv. Enzymol. Relat. Areas Mol. Biol. 58:61-97.
35. Gerber, H.-P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S., and Schaffner, W. (1994). Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:806-811.
36. Ghadge, G.D., Lee, J.P., Bindokas, V.P., Jordan, J., Ma, L., Miller, R.J., and Roos, R.P. (1997). Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis-molecular mechanisms of neuronal death and protection. J. Neurosci. 17:8756-8766.
37. Goldberg, Y.R., Nicholson, D.W., Rasper, D.M., Kalchman, M.A., Koide, H.B., Graham, R.K. et al. (1996). Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13:442-449.
38. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., and Schulte-Hermann, R. (1995). In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatol. 21:1465-1468.
39. Green, H. (1993). Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74:955-956.
40. Greenamyre, J.T. (1993). Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J. Neurol. Transm. 91:255-269.
41. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J. et al. (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615.
42. Gschwind, M., and Huber, G. (1995). Apoptic cell death induced by β-amyloid peptide is cell type dependent. J. Neurochem. 65:292-300.
43. Guo, Q., Furukawa, K., Sopher, B.L., Pham, D.G., Xie, J., Robinson et al. (1996). Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport 8:379-383.
44. Guo, Q., Sopher, B.L., Pham, D.G., Furukawa, K., Robinson, N., Martin, G.M., and Mattson, M.P. (1997). Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid b-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:4212-4222.
45. Hacker, G., and Vaux ,D.L. (1995). A sticky business. Curr. Biol. 5:622-624.
46. Halliwell, B. (1992). Oxygen radicals as key mediators in neurological disease: fact or fiction. Ann. Neurol. 32:S10-S15.
47. Hartley, A., Stone, J.M., Heron, C., Cooper, J.M., and Shapira, A.H.V. (1994). Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63:1987-1990.
48. Hengartner, M.O., and Horvitz, H.R. (1994). C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-676.
49. Hirsch, T., Marzo, I., and Kroemer, G. (1997). Role of the mitochondrial permeability transition pore in apoptosis. Biosci. Rep. 17:67-76.
50. Hu, J., Ferreira, A., and Van Eldik, L., (1997) S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69:2294-2301.
51. Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
52. Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S., and Kakizuka, A. (1996). Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13:196-202.
53. Iwahashi, H., Eguchi, Y., Yasuhara, N., Hanafusa, T., Matsuzawa, Y., and Tsujimoto, Y. (1997). Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 390:413-417.
54. Jacobson, M.D., Burne, J.F., and Raff, M.C. (1994). Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1899-1910.
55. Javitch, J.A., D'amato, R.J., Strittmatter, S.M., and Snyder, S.H. (1985). Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82:2173-2177.
56. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S. et al. (1994). CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet. 8:221-227.
57. Kluck, R.M., Martin, S.J., Hoffman, B.M., Zhou, J.S., Green, D.R., and Newmeyer, D.D. (1997a). Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16:4639-4649.
58. Kluck, R.M., Bossi-Wetzel, E., Green, D.R., and Newmeyer, D.D. (1997b). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
59. Kroemer, G., Petit, P., Zamzami, N., Vayssière, J.-L., and Mignotte, B. (1995). The biochemistry of programmed cell death. FASEB J. 9:1277-1287.
60. LaFerla, F.M., Tinkle, B.T., Bieberich, C.J., Haudenschild, C.C., and Jay, G. (1995). The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9:21-30.
61. Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., and Wisniewski, H.M. (1995). Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:35-41.
62. Le, W.D., Colom, L.V., Wie, W.J., Smith, R.G., Alexianu, M., and Appel, S.H. (1995). Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res. 686:49-60.
63. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L. et al. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155-165.
64. Leist, M., and Nicotera, P. (1998). Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239:183-201.
65. Lemere, C.A., Lopera, F., Kosik, K.S., Lendon, C.L., Ossa, J., Saido, T.C. et al. (1996). The E280A presenilin l Alzheimer mutation produces increase Aβ42 deposition and severe cerebellar pathology. Nature Med. 2:1146-1150.
66. Lennon, S.V., Martin, S.J., and Cotter, T.G. (1991). Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 24:203-214.
67. Lipton, S.A., and Rosenberg, P.A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. New Eng. J. Med. 330:613-622.
68. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G. et al. (1996). Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-353.
69. Liston, P., Young, S.S., Mackenzie, A.E., and Korneluk, R.G. (1997). Life and death decisions: the role of the IAPS in modulating programmed cell death. Apoptosis 2:423-441.
70. Liu, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptosis program in cell-free extracts: requirement for dATPand cytochrome c. Cell 86:147-157.
71. Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, J.A., and Cotman, C.W. (1993). Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90:7951-7955.
72. Majno, G., and Joris, I. (1995). Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146:3-15.
73. Martin, D.P., Schmidt, R.E., DiStefano, P. S., Lowry, O.H., Carter, J.G., and Johnson, E.M.Jr. (1988). Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106:829-844.
74. Martin, S.J., Lennon, S.V., Bonham, A.M., and Cotter, T.G. (1990). Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145:1859-1867.
75. Martin, S.J. (1993). Protein or RNA synthesis inhibition induces apoptosis of mature human CD4+ T cell blasts. Immuno. Lett. 35:125-134.
76. Martin, S.J., and Green, D.R. (1995). Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352.
77. Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D., and Games, D. (1996). Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:5795-5811.
78. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R.E. (1992). β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:376-389.
79. Mattson, M.P. (1998). Modification of ion homeostasis by lipid peroxidation: role in neuronal degeneration and adaptive plasticity. Trends in Neurol. Sci. 21:53-57.
80. Mattson, M.P., Guo, Q., Katsutoshi, F., and Pedersen, W.A. (1998). Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70:1-14.
81. Mhatre, A.N., Trifiro, M.A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G., and Pinsky, L. (1993). Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genet.5:184-188.
82. L forms an ion channel in synthetic lipid membranes. Nature 385:353-357.
83. Mizuno, Y., Suzuki, K., Sone, N., and Saitoh, T. (1987). Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium (MPP+) in isolated mitochondrial from mouse brain. Neurosci. Lett. 81:204-208.
84. Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y. (1996). Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137:120-123.
85. Mu, X., He, J., Anderson, D.W. Trojanowski, J.Q., and Springer, J.E. (1996). Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40:379-386.
86. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J. et al. (1995). Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811-823.
87. Offen, D., Ziv, I., Panet, H., Wasserman, L., Stein, R., Melamed, E., and Barzilai, A. (1997). Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2. Cell. Mol. Neurobiol. 17:289-304.
88. Olanow, C.W. (1993). A radical hypothesis for neurodegeneration. Trends Neurosci. 16:439-444.
89. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, J.S. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
90. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 273:5841-5845.
91. Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C., and LeBlanc, A. (1996). Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci. 16:7533-7539.
92. Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D. et al. (1997a). Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann. Neurol. 41: 453-462.
93. Paulson, H.L., Perez, M.K., Trottier, Y., Trojanowski, J.Q., Subramony, S.H., Das, S.S. et al. (1997b). Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19:333-344.
94. Perutz, M.F., Johnson, T., Suzuki, M., and Finch, J.T. (1994). Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91:5355-5358.
95. Portera-Cailliau, C., Hedreen, J.C., Price, D.L., and Koliatsos, V.E. (1995). Evidence for apoptotic cell death in Huntington disease and excitoxic animal models. J. Neurosci. 15:3775-3787.
96. Rabizadeh, S., Bitler, C.M., Butcher, L.L., and Bredesen, D.E. (1994). Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity. Proc. Natl. Acad. Sci. USA 91:10,703-10,706
97. Rabizadeh, S., Gralla, E.B., Borchelt, D.R., Gwinn, R., Valentine, J.S., Sisodia, S. et al. (1995). Mutations associated with amyotrophic lateral sclerosis convert Superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA 92:3024-3028.
98. Raff, M.C. (1992). Social controls on cell survival and cell death. Nature 356:397-400.
99. Ratan, R.R., Murphy, T.H., and Baraban, J.M. (1994). Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:376-379.
100. Rebeck, G.W., Reiter, J.S., Strickland, D.K., and Hyman, B.T. (1993). Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11:575-580.
101. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A. et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
102. Rothstein, J.F., Van Kammen, M., Levey, A.I., Martin, L.J., and Kuncl, R.W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:73-84.
103. Roy, N., Mahadevan, M.S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R. et al. (1995). The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167-178.
104. Sakahira, H., Enari, M., and Nagata, S. (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99.
105. Savitz, S.I., and Rosenbaum, D.M. (1998). Apoptosis in neurological diseases. Neurosurgery 42:555-574.
106. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H. et al. (1993). Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:9649-9653.
107. Schrank, B., Gotz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G., and Sendtner M. (1997). Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl. Acad. Sci. USA 94:9920-9925.
108. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E., and Horton, Jr. W.E. (1995). Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:225-230.
109. Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.M., Salvesen, G.S., Pericak-Vance, M. et al. (1993). Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:8098-8102.
110. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., and Roses A.D. (1994). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1977-1981.
111. Su, J.H., Anderson, A.J., Cummings, B.J., and Cotman, C.W. (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5:2529-2533.
112. Su, J.H., Deng, G., and Cotman, C.W. (1997). Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression and brain pathology. J. Neuropathol. Exp. Neurol. 56:86-93.
113. Tatton, N.A., and Kish, S.J. (1997). In situ detection of apoptotic nuclei in the substantia nigra compacta of MPTP-treated mice using TdT labeling and acridine orange staining. Neurosci. 77:1037-1048.
114. Thomas, L.B., Gates, D.J., Richfield, E.X., Obrien, T.F., Schweitzer, J.B., and Steindler, D.A. (1995). DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133:265-272.
115. Tomei, L.D., Shapiro, J.P., and Cope, F.O. (1992). Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA 90:853-857.
116. Tompkins, MM., Basgall, E.J., Zamrini, E., and Hill, W.D. (1997). Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150:119-131.
117. Troncoso, J.C., Sukhov, R.R., Kawas, C.H., and Koliatsos, V.E. (1996). In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J. Neuropathol. Exp. Med. 55:1134-1142.
118. Vaux, D.L. (1993). Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Nad. Acad. Sci. USA 90:786-789.
119. Walkinshaw, G., and Waters, C.M. (1994). Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neurosci. 63:975-987.
120. White, E. (1996). Life, death, and the pursuit of apoptosis. Genes & Dev. 10:1-15.
121. Wiedau-Pazos, M., Goto, J.J., Rabizadeh, S., Gralla, E.B., Roe, J.A., Lee, M.K. et al. (1996). Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271:515-518.
122. Wisniewski, T., Golabek, A., Matsubara, E., Ghiso, J., and Frangione, B. (1993). Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Comm. 192:359-365.
123. Wisniewski, T., Ghiso, J., and Frangione, B. (1994). Alzheimer's disease and soluble A beta. Neurobiol. Aging 15:143-152.
124. Wolozin, B., Iwasaki, K., Vito, P, Ganjei, J.K., Lacan, E., Sunderland, T. et al. (1996). Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274:1710-1713.
125. Won, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins N.A. et al. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria Neuron 14:1105-1116.
126. Wyllie, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556 .
127. Wyllie, A.H., Morris, R.G., Smith, A.L., and Dunlop, D. (1984). Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142:67-77.
128. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J. et al. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
129. Yin, X.-M., Oltvai, Z.N., and Korsmeyer, S.J. (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323.
130. Yuan, J., and Horvitz, H.R. (1992). The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 116:309-320.
131. Yuan, J., Shaham, S., Ledoux, S, Ellis, H.M., and Horvitz, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-652.
132. Zamzami, N., Hirsch, T., Dallaporta, B., Petit, P.X., and Kroemer, G. (1997). Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. &Biomemb.29:185-193.
133. Zeitlin, S., Liu, J.-P., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1995). Increased apoptosis and arly embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11:155-163.
134. Zhao, B., Chrest, F.J., Horton, Jr. W.E., Sisodia, S.S., and Kusiak, J.W. (1997). Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J. Neurosci. Res. 47:253-263.
135. Ziv, I., Offen, D., Barzilai, A., Haviv, R., Stein, R., Zilkhafalb, R. et al. (1997). Modulation of control mechanisms of dopamine-induced apoptosis-a future approach to the treatment of Parkinson's disease. J. Neural Transm. 849:195-202.
136. Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. (1997). Apaf-1, a human protein homologous to C. elegans CED-4 participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.